Skip to main content
Journal cover image

Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis.

Publication ,  Journal Article
Garza-Elizondo, AK; Oscherwitz, M; Cervantes-Ramirez, V; Salazar-Marentes, E; Galarza-Delgado, DA; Cardenas-de la Garza, JA
Published in: International journal of rheumatic diseases
October 2024

Duke Scholars

Published In

International journal of rheumatic diseases

DOI

EISSN

1756-185X

ISSN

1756-1841

Publication Date

October 2024

Volume

27

Issue

10

Start / End Page

e15365

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Tumor Necrosis Factor Inhibitors
  • Treatment Outcome
  • Sarcoma, Kaposi
  • Pyrimidines
  • Pyrazoles
  • Middle Aged
  • Male
  • Janus Kinase Inhibitors
  • Iatrogenic Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Garza-Elizondo, A. K., Oscherwitz, M., Cervantes-Ramirez, V., Salazar-Marentes, E., Galarza-Delgado, D. A., & Cardenas-de la Garza, J. A. (2024). Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis. International Journal of Rheumatic Diseases, 27(10), e15365. https://doi.org/10.1111/1756-185x.15365
Garza-Elizondo, Angel Kevin, Max Oscherwitz, Valeria Cervantes-Ramirez, Enrique Salazar-Marentes, Dionicio Angel Galarza-Delgado, and Jesus Alberto Cardenas-de la Garza. “Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis.International Journal of Rheumatic Diseases 27, no. 10 (October 2024): e15365. https://doi.org/10.1111/1756-185x.15365.
Garza-Elizondo AK, Oscherwitz M, Cervantes-Ramirez V, Salazar-Marentes E, Galarza-Delgado DA, Cardenas-de la Garza JA. Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis. International journal of rheumatic diseases. 2024 Oct;27(10):e15365.
Garza-Elizondo, Angel Kevin, et al. “Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis.International Journal of Rheumatic Diseases, vol. 27, no. 10, Oct. 2024, p. e15365. Epmc, doi:10.1111/1756-185x.15365.
Garza-Elizondo AK, Oscherwitz M, Cervantes-Ramirez V, Salazar-Marentes E, Galarza-Delgado DA, Cardenas-de la Garza JA. Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis. International journal of rheumatic diseases. 2024 Oct;27(10):e15365.
Journal cover image

Published In

International journal of rheumatic diseases

DOI

EISSN

1756-185X

ISSN

1756-1841

Publication Date

October 2024

Volume

27

Issue

10

Start / End Page

e15365

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Tumor Necrosis Factor Inhibitors
  • Treatment Outcome
  • Sarcoma, Kaposi
  • Pyrimidines
  • Pyrazoles
  • Middle Aged
  • Male
  • Janus Kinase Inhibitors
  • Iatrogenic Disease